β‐2 Adrenergic receptor gene methylation is associated with decreased asthma severity in inner‐city Schoolchildren
- 17 October 2013
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 44 (5) , 681-689
Abstract
Summary: Background: Genetic variation in the β‐2 adrenergic receptor gene (ADRB2) has been implicated in asthma severity and control with conflicting results. Epigenetic variation in the ADRB2 may play an important role in asthma phenotype.Objective: We aimed to evaluate whether DNA methylation of ADRB2 is associated with asthma phenotypes in inner‐city school‐aged children.Methods: Multiple CpG sites in the promoter region of ADRB2 gene were analysed in 177 children enrolled in the School Inner‐City Asthma Study. Blood‐ or saliva‐derived DNA was measured by bisulphite‐polymerase chain reaction pyrosequencing assay. Average percentage DNA methylation across the sites was evaluated for association with asthma severity (report of dyspnoea, night‐time symptoms, rescue medication use, and baseline spirometry) and morbidity (school absences and unscheduled healthcare visits). Three clades composed of highly correlated methylation sites within the methylated segment of ADRB2 were further analysed.Results: Methylation of individual sites generally ranged from 0% to 6% with average percentage methylation across sites of 2.4%. Univariate analyses strongly favoured the association of higher percentage methylation with lower asthma severity measured by report of dyspnoea. Furthermore, there was a non‐significant trend towards less rescue medication use, night‐time symptoms, school absences, activity limitation due to asthma, and improved lung function measurements with increased methylation. Multivariate analysis demonstrated methylation of ADRB2 gene significantly associated with less dyspnoea (odds ratio (OR) 0.2, 95% confidence interval (CI), 0.1–0.6, P = 0.002). Each of the three clades of methylation sites showed a strong, but not statistically significant, effect on decreased dyspnoea.Conclusions and Clinical Relevance: DNA methylation in the ADRB2 gene is associated with decreased asthma symptom severity, suggesting a role for methylation in asthma phenotypes.Keywords
This publication has 50 references indexed in Scilit:
- 450K Epigenome-Wide Scan Identifies Differential DNA Methylation in Newborns Related to Maternal Smoking during PregnancyEnvironmental Health Perspectives, 2012
- The School Inner-City Asthma Study: Design, Methods, and Lessons LearnedJournal of Asthma, 2011
- DNA Methylation in the Arginase–Nitric Oxide Synthase Pathway Is Associated with Exhaled Nitric Oxide in Children with AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Epigenetic regulation of beta2-adrenergic receptor expression in TH1 and TH2 cellsBrain, Behavior, and Immunity, 2011
- Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genomeGenome Research, 2010
- Allelic Skewing of DNA Methylation Is Widespread across the GenomeThe American Journal of Human Genetics, 2010
- Prenatal Tobacco Smoke Exposure Affects Global and Gene-specific DNA MethylationAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996
- Decreased Beta-Adrenergic Receptors on Polymorphonuclear Leukocytes after Adrenergic TherapyNew England Journal of Medicine, 1978
- The beta adrenergic theory of the atopic abnormality in bronchial asthmaJournal of Allergy, 1968